CA

Wendy A Hutchins

This inventor holds 1 USPTO granted patent. Top assignee: Sembiosys Genetics, Inc.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendy A Hutchins. Retrieved from https://idiyas.com/inventor/wendy-a-hutchins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wendy A. Hutchins: Innovator in Immunogenic Formulations

Introduction

Wendy A. Hutchins is a notable inventor based in California, recognized for her contributions to the field of immunology. She has developed innovative solutions that enhance vaccine efficacy through novel adjuvants.

Latest Patents

Wendy holds a patent for "Immunogenic formulations comprising oil bodies." This invention provides novel adjuvants that comprise oil bodies, which are crucial in formulating vaccines. The patent outlines methods for preparing these vaccines and their use in eliciting an immune response.

Career Highlights

Wendy is associated with Sembiosys Genetics, Inc., where she applies her expertise in developing cutting-edge immunological products. Her work focuses on improving vaccine formulations to better protect against various diseases.

Collaborations

Wendy collaborates with esteemed colleagues, including Harm M. Deckers and Gijs Van Rooijen, to advance research in immunogenic formulations.

Conclusion

Wendy A. Hutchins is a pioneering inventor whose work in immunogenic formulations significantly contributes to the field of vaccine development. Her innovative approaches are paving the way for more effective immunization strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…